Published in Clinical Oncology Week, April 3rd, 2006
Novelos has agreed to sell an aggregate of 11.15 million shares of common stock at a price of $1.35 per share. The investors will also receive warrants to purchase an aggregate of 8.37 million shares of common stock at an exercise price of $2.50 per share.
Oppenheimer & Co. and Rodman & Renshaw are serving as the placement...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.